Status:
COMPLETED
Intracochlear Dexamethasone Application During Cochlear Implantation for Preserving Cochlear Cells
Lead Sponsor:
Pamukkale University
Conditions:
Hearing Loss, Sensorineural
Eligibility:
All Genders
Phase:
NA
Brief Summary
The protection of cochlear cells is one of the main concerns of cochlear implant surgery. New electrode designs or additional molecules have been used for this purpose. The aim of the study is to test...
Detailed Description
The protection of cochlear cells is one of the main concerns of cochlear implant surgery. New electrode designs or additional molecules have been used for this purpose. The aim of the study is to test...
Eligibility Criteria
Inclusion
- Patients with sensorineural hearing loss
- Patients who will have cochlear implant surgery with CI422 electrode
Exclusion
- Patients with cochlear abnormality
- Patients with auditory neuropathy
Key Trial Info
Start Date :
March 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 20 2022
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT04397354
Start Date
March 2 2020
End Date
September 20 2022
Last Update
January 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pamukkale University
Denizli, Turkey (Türkiye), 20070